electroCore (NASDAQ:ECOR) issued an update on its first quarter 2021 earnings guidance on Tuesday morning. The company provided EPS guidance of – for the period. The company issued revenue guidance of $1.10 M-, compared to the consensus revenue estimate of $1.04 million.
Shares of ECOR stock traded up $0.02 during trading hours on Tuesday, hitting $1.78. The company had a trading volume of 753,515 shares, compared to its average volume of 3,353,292. The company’s fifty day moving average is $1.97 and its 200 day moving average is $1.94. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.92 and a quick ratio of 4.78. electroCore has a fifty-two week low of $0.77 and a fifty-two week high of $3.63. The stock has a market capitalization of $86.40 million, a PE ratio of -2.22 and a beta of 1.62.
electroCore (NASDAQ:ECOR) last issued its quarterly earnings data on Wednesday, March 10th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.04). electroCore had a negative return on equity of 109.15% and a negative net margin of 792.01%. The company had revenue of $0.93 million during the quarter, compared to analyst estimates of $0.94 million. Equities analysts forecast that electroCore will post -0.58 earnings per share for the current year.
electroCore Company Profile
electroCore, Inc, a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Read More: What are different types of coverage ratios?
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.